× |
|
Health Benefit Costs and Absenteeism Due to Insomnia From the Employer's Perspective: A Retrospective, Case-Control, Database Study PDF |
$40.00 |
|
$40.00 |
× |
|
A Randomized Pilot Study of the Efficacy and Safety of ABT-089, a Novel α4β2 Neuronal Nicotinic Receptor Agonist, in Adults With Attention-Deficit/Hyperactivity Disorder PDF |
$40.00 |
|
$40.00 |
× |
|
Functional Versus Syndromal Recovery in Patients With Major Depressive Disorder and Bipolar Disorder PDF |
$40.00 |
|
$40.00 |
× |
|
Affect Following First Exercise Session as a Predictor of Treatment Response in Depression PDF |
$40.00 |
|
$40.00 |
× |
|
Safety of Mirtazapine in Overdose PDF |
$40.00 |
|
$40.00 |
× |
|
Venlafaxine in Dysthymic Disorder PDF |
$40.00 |
|
$40.00 |
× |
|
Posttraumatic Stress Disorder Among Hospital Surgical Physicians Exposed to Victims of Terror: A Prospective, Controlled Questionnaire Survey PDF |
$40.00 |
|
$40.00 |
× |
|
Tardive Dyskinesia: Is Vitamin E Singing the Prostate Blues? PDF |
$40.00 |
|
$40.00 |
× |
|
Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder PDF |
$40.00 |
|
$40.00 |
× |
|
Unemployment and Emergency Room Visits Predict Poor Treatment Outcome in Primary Care Panic Disorder PDF |
$40.00 |
|
$40.00 |
× |
|
Prescriptions, Nonmedical Use, and Emergency Department Visits Involving Prescription Stimulants PDF |
$40.00 |
|
$40.00 |
|